These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31210677)

  • 1. Comparison of essential medicines lists in 137 countries.
    Persaud N; Jiang M; Shaikh R; Bali A; Oronsaye E; Woods H; Drozdzal G; Rajakulasingam Y; Maraj D; Wadhawan S; Umali N; Wang R; McCall M; Aronson JK; Plüddemann A; Moja L; Magrini N; Heneghan C
    Bull World Health Organ; 2019 Jun; 97(6):394-404C. PubMed ID: 31210677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists.
    Richards GC; Aronson JK; Heneghan C; Mahtani KR; Koshiaris C; Persaud N
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33173012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential medicines for cancer: WHO recommendations and national priorities.
    Robertson J; Barr R; Shulman LN; Forte GB; Magrini N
    Bull World Health Organ; 2016 Oct; 94(10):735-742. PubMed ID: 27843163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study.
    Taglione MS; Persaud N
    BMJ Open; 2021 Aug; 11(8):e045262. PubMed ID: 34380717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawn medicines included in the essential medicines lists of 136 countries.
    Charles O; Onakpoya I; Benipal S; Woods H; Bali A; Aronson JK; Heneghan C; Persaud N
    PLoS One; 2019; 14(12):e0225429. PubMed ID: 31791048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
    Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
    Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list.
    Slamang W; Scott C; Foster HE
    Pediatr Rheumatol Online J; 2024 Jul; 22(1):63. PubMed ID: 38965620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations.
    Todesco B; Ostuzzi G; Gastaldon C; Papola D; Barbui C
    Arch Public Health; 2023 Jan; 81(1):8. PubMed ID: 36653880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In which developing countries are patents on essential medicines being filed?
    Beall RF; Blanchet R; Attaran A
    Global Health; 2017 Jun; 13(1):38. PubMed ID: 28651631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
    Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
    BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region.
    Mehrtash H; Laing R; Wirtz VJ
    East Mediterr Health J; 2018 Jul; 24(5):427-434. PubMed ID: 30043961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
    Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
    Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
    Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
    PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic medicine inclusion in 138 national essential medicines lists.
    Kraus R; Yeung RSM; Persaud N
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):140. PubMed ID: 34488779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On Essentiality and the World Health Organization's Model List of Essential Medicines.
    Marks VA; Latham SR; Kishore SP
    Ann Glob Health; 2017; 83(3-4):637-640. PubMed ID: 29221540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
    Chivukula MV; Tisocki K
    WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengthening regional commitment to ensuring access to medical abortion medicines in WHO's South-East Asia region: report of a participatory assessment and workshop.
    Upadhyay MT; Fusire T; Loi UR; Sorhaindo A; Salahuddin M; Hossain MA; Tshomo T; Mulati E; Daisy L; Anggraweni DP; Gultom T; Indrawati F; Jenyfa M; Than MM; Bhattarai B; Moonasinghe L; Mathota C; Jitruknatee A; Cham C; Ganatra B; Raina N
    Reprod Health; 2024 May; 20(Suppl 1):191. PubMed ID: 38760864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of national essential medicines lists in the Americas.
    Steiner L; Maraj D; Woods H; Jarvis J; Yaphe H; Adekoya I; Bali A; Persaud N
    Rev Panam Salud Publica; 2020; 44():e5. PubMed ID: 31998375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list.
    Maraj D; Steiner L; Persaud N
    J Clin Tuberc Other Mycobact Dis; 2022 May; 27():100305. PubMed ID: 35308809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.